Showing 2141-2150 of 3315 results for "".
- Medical Specialty Organizations Applaud Introduction of Congressional Legislation to Improve Transparency in Prior Authorizationhttps://modernod.com/news/medical-specialty-organizations-applaud-introduction-of-congressional-legislation-to-improve-oversight-and-transparency-in-prior-authorization/2476633/A coalition of eight national medical specialties, including the American Academy of Ophthalmology, pledged support for the bipartisan “Improving Seniors’ Timely Access to Care Act of 2019” (H.R. 3107) legislation that aims to protect patients from unreasonable Medicare Advantag
- Lens Replacement Because of Cataracts May Improve Sleephttps://modernod.com/news/lens-replacement-because-of-cataracts-may-improve-sleep/2476610/Seniors who get new lenses implanted during cataract surgery may not only see better but also experience better sleep, suggests a new study of how light entering the eye regulates the body’s internal clock, according to a Reuters
- NTC Grants Further License and Distribution Rights to Santen for Its Fixed Combination Dexamethasone With Levofloxacinhttps://modernod.com/news/ntc-grants-further-license-and-distribution-rights-to-santen-for-its-fixed-combination-dexamethasone-with-levofloxacin-in-south-east-asia/2476602/Italy-based NTC Srl and Santen Pharmaceutical announced an extension of their original agreement for Europe granting NTC’s license and distribution rights of levofloxacin+dexamethasone fixed combination eye drops to Santen. The countries covered by the exten
- Zeiss Opens Cinema Lens Demo Center in Los Angeleshttps://modernod.com/news/zeiss-opens-cinema-lens-demo-center-in-los-angeles/2476584/For over 100 years, Zeiss has provided cinematography lenses to filmmakers at all levels. From their headquarters in Germany, each cine lens is designed and manufactured at the highest quality and exhibits the versatile look with neutral color rendition Zeiss is k
- The Healthcare Alliance for Patient Safety Statement in Response to FTC Proposed Contact Lens Rulehttps://modernod.com/news/the-healthcare-alliance-for-patient-safety-statement-in-response-to-ftc-proposed-contact-lens-rule/2476553/The Healthcare Alliance for Patient Safety (Alliance) released the following statement in response to last week’s Federal Trade Commission (FTC) proposed supplemental rulemaking on the 2016 proposed Contact Lens Rule. Congress charged the FTC with enforcing contact lens prescription
- Leiters Now Integrated into Besse Medical’s Inventory Management Systemshttps://modernod.com/news/leiters-now-integrated-into-besse-medicals-inventory-management-systems/2476547/Leiters and Besse Medical announced that they have entered into a national agreement to provide ophthalmic medications that are compatible with Besse Medical’s inventory management systems, CubixxMD and PODIS Plus. This new agreement enables Leiters’ full suite of ophthalmic medicatio
- SightGlass Vision Presents Clinical Trial Data From Novel Lenses to Control Myopiahttps://modernod.com/news/sightglass-vision-presents-clinical-trial-data-from-novel-lenses-to-control-myopia/2476541/SightGlass Vision announced that data assessing the tolerability of three iterations of its novel lenses designed to control nearsightedness in children were presented at the Association for Research in Vision and
- Lensar Laser System Receives FDA Clearance to Perform Micro Radial Incisions for Refractive Cataract Procedureshttps://modernod.com/news/lensar-laser-system-receives-fda-clearance-to-perform-micro-radial-incisions-for-refractive-cataract-procedures/2476537/Lensar announced it received 510(k) clearance from the FDA for the Lensar Laser System with Streamline IV, expanding the platform’s capabilities to include the creation of micro radial incisions that allow surgeons to treat additional corneal conditions post cataract surgery. “This indicat
- Bausch + Lomb Announces New Divisional Leadership in the UShttps://modernod.com/news/bausch-lomb-announces-new-divisional-leadership-in-the-us/2476487/Bausch + Lomb announced the appointment of new leadership in its Pharmaceuticals and Consumer Health Care divisions in the United States. Yolande Barnard, formerly the vice president, marketing and sales, U.S. Neurology, Bausch Health, will now serve as vice president and general manager,
- Akorn Receives FDA Approval for Generic Loteprednol Etabonatehttps://modernod.com/news/akorn-receives-fda-approval-for-generic-loteprednol-etabonate/2476485/Akorn announced that it received an abbreviated new drug application (NDA) approval from the FDA for loteprednol etabonate ophthalmic suspension, 0.5%. Loteprednol etabonate 0.5% is indicated for the treatment of postoperative inflammation following ocular surgery